Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ronald W Gottschalk, MD
Galderma R&D
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- East Bay Dermatology Medical Group, Inc.
Fremont, California, United States
- Solano Clinical Research
Vallejo, California, United States
- Henry Ford Medical Center
Detroit, Michigan, United States
- Minnesota Clinical Study Center
Fridley, Minnesota, United States
- Dermatology Associates of Rochester
Rochester, New York, United States
- Baylor Research Institute - Dermatology Research
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2007
- Primary completion
- 30 Apr 2008
- Completion
- 30 Apr 2008
- Last update posted
- 23 Aug 2022
- Registered enrollment
- 250
- Registry id
- NCT00733954
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.